Cargando…

Isolating pulmonary microvascular endothelial cells ex vivo: Implications for pulmonary arterial hypertension, and a caution on the use of commercial biomaterials

Transcriptomic analysis of pulmonary microvascular endothelial cells from experimental models offers insight into pulmonary arterial hypertension (PAH) pathobiology. However, culturing may alter the molecular profile of endothelial cells prior to analysis, limiting the translational relevance of res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wertheim, Bradley M., Lin, Yi-Dong, Zhang, Ying-Yi, Samokhin, Andriy O., Alba, George A., Arons, Elena, Yu, Paul B., Maron, Bradley A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392245/ https://www.ncbi.nlm.nih.gov/pubmed/30811450 http://dx.doi.org/10.1371/journal.pone.0211909

Ejemplares similares

Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS‐CoV‐2 infection
por: Alba, George A., et al.
Publicado: (2022)

Proline and glucose metabolic reprogramming supports vascular endothelial and medial biomass in pulmonary arterial hypertension
por: Wertheim, Bradley M., et al.
Publicado: (2023)

Introducing the Pulmonary Hypertension Thematic Series
por: Maron, Bradley A.
Publicado: (2023)

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Leopold, Jane A., et al.
Publicado: (2016)

Pulmonary arterial hypertension: Cellular and molecular changes in the lung
por: Maron, Bradley A.
Publicado: (2020)

New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension
por: Wertheim, Bradley M.
Publicado: (2022)

Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics
por: Maron, Bradley A.
Publicado: (2020)

Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer
por: Maron, Bradley A.
Publicado: (2023)

Pulmonary arterial hypertension: Rationale for using multiple vs. single drug therapy
por: Maron, Bradley A.
Publicado: (2020)

TORward a Molecular Convergence Point in Pulmonary Arterial Hypertension With mTOR
por: Maron, Bradley A., et al.
Publicado: (2018)

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Patients With Chronic Obstructive Pulmonary Disease: A Note of Caution
por: Cheng, Richard, et al.
Publicado: (2023)

Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction. Where to Draw the Line
por: Simon, Marc A., et al.
Publicado: (2019)

Pulmonary Embolectomy for Acute Pulmonary Embolism: A Word of Caution
por: Inui, Tomohiko, et al.
Publicado: (2020)

Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure
por: Oliveira, Rudolf K. F., et al.
Publicado: (2017)

Chronic Thromboembolic Pulmonary Hypertension: the Bedside
por: Matusov, Yuri, et al.
Publicado: (2021)

Echocardiographic Predictors of Mortality in Patients with Pulmonary Hypertension and Cardiopulmonary Comorbidities
por: Steiner, Johannes, et al.
Publicado: (2015)

Method for the Culture of Mouse Pulmonary Microvascular Endothelial Cells
por: Kovacs-Kàsa, Anita, et al.
Publicado: (2017)

Pulmonary Arterial Hypertension and Insulin Resistance
por: Bradley, Elisa A, et al.
Publicado: (2014)

Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement?
por: Frid, Maria G., et al.
Publicado: (2020)

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Maron, Bradley A., et al.
Publicado: (2021)

Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Maron, Bradley A., et al.
Publicado: (2022)

DDAH1 regulates apoptosis and angiogenesis in human fetal pulmonary microvascular endothelial cells
por: Trittmann, Jennifer K., et al.
Publicado: (2019)

CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension
por: Sun, Yuanyuan, et al.
Publicado: (2022)

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease
por: Gillmeyer, Kari R., et al.
Publicado: (2021)

Pulmonary hypertensive crisis in children with pulmonary arterial hypertension undergoing cardiac catheterization
por: Li, Qiangqiang, et al.
Publicado: (2022)

Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension
por: Gillmeyer, Kari R., et al.
Publicado: (2022)

Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?
por: Dintakurti, Sri Harsha, et al.
Publicado: (2023)

Lipidomics for diagnosis and prognosis of pulmonary hypertension
por: Bordag, Natalie, et al.
Publicado: (2023)

Mild Pulmonary Hypertension Is Associated With Increased Mortality: A Systematic Review and Meta‐Analysis
por: Kolte, Dhaval, et al.
Publicado: (2018)

Caution with explant of prestented percutaneous pulmonary valves with infective endocarditis
por: Woods, Ronald K., et al.
Publicado: (2023)

Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo
por: Gill, Sean E., et al.
Publicado: (2015)

Heat stress combined with lipopolysaccharide induces pulmonary microvascular endothelial cell glycocalyx inflammatory damage in vitro
por: Chen, Jiadi, et al.
Publicado: (2023)

Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
por: Smolders, V. F. E. D., et al.
Publicado: (2022)

Effect of asiaticoside on endothelial cells in hypoxia-induced pulmonary hypertension
por: Wang, Xiaobing, et al.
Publicado: (2018)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
por: Johnson, Shelsey W., et al.
Publicado: (2022)

Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease
por: Kuek, Stephanie L., et al.
Publicado: (2021)

Second International Pulmonary Hypertension/Heart Failure Symposium—Structural heart disease, right ventricular dysfunction, and stem cell therapy: The European Pediatric Pulmonary Vascular Disease Network
por: Chouvarine, Philippe, et al.
Publicado: (2023)

Mechanical stretch enhances IL-8 production in pulmonary microvascular endothelial cells
por: Iwaki, Mai, et al.
Publicado: (2009)

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension
por: Hautefort, Aurélie, et al.
Publicado: (2017)

Use of Oxidized Regenerated Cellulose in Patients with Lung Cancer: A Biomaterial to Handle with Caution!
por: Franceschini, Gianluca
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_74kg6c1rs2mco4e121989krpga